Publications
- Combined Approach to Leukemic Differentiation Using Transcription Factor PU.1-Enhancing Agents2022 | First Faculty of Medicine
- Somatic Mutations in Oncogenes Are in Chronic Myeloid Leukemia Acquired De Novo via Deregulated Base-Excision Repair and Alternative Non-Homologous End Joining2021 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- BCR-ABL1 mediated miR-150 downregulation through MYC contributed to myeloid differentiation block and drug resistance in chronic myeloid leukemia.2018 | First Faculty of Medicine, Central Library of Charles University
- miR-150 downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels2018 | First Faculty of Medicine, Third Faculty of Medicine
- BCR-ABL1 mediated miR-150 downregulation through MYC contributed to myeloid differentiation block and drug resistance in chronic myeloid leukemia2018 | First Faculty of Medicine, Central Library of Charles University
- GATA-1 Inhibits PU.1 Gene via DNA and Histone H3K9 Methylation of Its Distal Enhancer in Erythroleukemia2016 | First Faculty of Medicine
- Aggressive acute myeloid leukemia in PU.1/p53 double-mutant mice2014 | First Faculty of Medicine
- 5-Azacitidine in aggressive myelodysplastic syndromes regulates chromatin structure at PU.1 gene and cell differentiation capacity2012 | First Faculty of Medicine
- Expression patterns of microRNAs associated with CML phases and their disease related targets2011 | First Faculty of Medicine
- Oncogenic MicroRNAs: miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serum2014 | First Faculty of Medicine, Faculty of Mathematics and Physics
Loading network view...